Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma.

Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma.
复制标题

DOI:
10.1038/nm.3716
复制
发表时间:
2014-12
期刊:
影响因子:
82.9
通讯作者:
--
中科院分区:
医学1区
文献类型:
--
作者:

文献摘要

参考文献

被引文献

相似文献

儿童脑干神经胶质瘤通常具有组蛋白H3.3的致癌K27M突变。我们发现GSKJ4对K27去甲基化酶JMJD3的药理学抑制作用增加了K27 M肿瘤细胞中H3K27的甲基化,并在体外和体内对K27 M异种移植物显示了有效的抗肿瘤活性。我们的研究结果表明,通过抑制K27去甲基化酶来增加H3K27甲基化是治疗表达K27 M的脑干胶质瘤的有效治疗策略。
Pediatric brainstem gliomas often harbor oncogenic K27M mutation of histone H3.3. Here we show that GSKJ4 pharmacologic inhibition of K27 demethylase JMJD3 increases cellular H3K27 methylation in K27M tumor cells and demonstrate potent antitumor activity bothin vitroagainst K27M cells andin vivoagainst K27M xenografts. Our results demonstrate that increasing H3K27 methylation by inhibiting K27 demethylase is a valid therapeutic strategy for treating K27M-expressing brainstem glioma.
DOI: 10.1038/nature06145
发表时间: 2007-10-11
期刊: NATURE
影响因子: 64.8
作者:
Agger, Karl;Cloos, Paul A. C.;Helin, Kristian
通讯作者: Helin, Kristian
DOI: 10.1038/ng.1102
发表时间: 2012-01-29
期刊: NATURE GENETICS
影响因子: 30.8
作者:
Wu, Gang;Broniscer, Alberto;McEachron, Troy A.;Lu, Charles;Paugh, Barbara S.;Becksfort, Jared;Qu, Chunxu;Ding, Li;Huether, Robert;Parker, Matthew;Zhang, Junyuan;Gajjar, Amar;Dyer, Michael A.;Mullighan, Charles G.;Gilbertson, Richard J.;Mardis, Elaine R.;Wilson, Richard K.;Downing, James R.;Ellison, David W.;Zhang, Jinghui;Baker, Suzanne J.
通讯作者: Baker, Suzanne J.
DOI: 10.1093/neuonc/not220
发表时间: 2014-03-01
期刊: NEURO-ONCOLOGY
影响因子: 15.9
作者:
Mueller, Sabine;Hashizume, Rintaro;Haas-Kogan, Daphne A.
通讯作者: Haas-Kogan, Daphne A.
DOI: 10.1016/j.ccr.2013.10.006
发表时间: 2013-11-11
期刊: CANCER CELL
影响因子: 50.3
作者:
Bender, Sebastian;Tang, Yujie;Pfister, Stefan M.
通讯作者: Pfister, Stefan M.
DOI: 10.1101/gad.217778.113
发表时间: 2013-05-01
影响因子: 10.5
作者:
Chan, Kui-Ming;Fang, Dong;Zhang, Zhiguo
通讯作者: Zhang, Zhiguo